Product NDC: | 0068-0597 |
Proprietary Name: | Rifadin IV |
Non Proprietary Name: | rifampin |
Active Ingredient(s): | 600 mg/10mL & nbsp; rifampin |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0068-0597 |
Labeler Name: | Sanofi-Aventis U.S. LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA050627 |
Marketing Category: | NDA |
Start Marketing Date: | 19890525 |
Package NDC: | 0068-0597-01 |
Package Description: | 10 mL in 1 VIAL, GLASS (0068-0597-01) |
NDC Code | 0068-0597-01 |
Proprietary Name | Rifadin IV |
Package Description | 10 mL in 1 VIAL, GLASS (0068-0597-01) |
Product NDC | 0068-0597 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | rifampin |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 19890525 |
Marketing Category Name | NDA |
Labeler Name | Sanofi-Aventis U.S. LLC |
Substance Name | RIFAMPIN |
Strength Number | 600 |
Strength Unit | mg/10mL |
Pharmaceutical Classes | Rifamycin Antibacterial [EPC],Rifamycins [Chemical/Ingredient] |